Non-Invasive Prenatal Testing (NIPT) Market is expected to Hit US$ 22.41 billion by 2033 | Major Companies - Illumina, Inc, BGI Genomics Co., Ltd., Qiagen N.V.

AI Briefing

• – Non-Invasive Prenatal Testing Market expected to reach US$ 22.41 billion by 2033, driven by growing demand for accurate and early detection of genetic disorders, major players include Illumina, Inc, BGI Genomics Co., Ltd, and Qiagen N.V.
• – Increasing adoption of NIPT in hospitals and clinics, coupled with advancements in technology and decreasing costs, are key factors driving market growth
• – DataM Intelligence report highlights the need for early intervention and personalized medicine, leading to a growing demand for NIPT services globally